These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 18094959)

  • 1. New plasmid-mediated resistances to antimicrobial agents.
    Courvalin P
    Arch Microbiol; 2008 Apr; 189(4):289-91. PubMed ID: 18094959
    [No Abstract]   [Full Text] [Related]  

  • 2. Interaction of plasmid and host quinolone resistance.
    Martínez-Martínez L; Pascual A; García I; Tran J; Jacoby GA
    J Antimicrob Chemother; 2003 Apr; 51(4):1037-9. PubMed ID: 12654766
    [No Abstract]   [Full Text] [Related]  

  • 3. Investigation of plasmid-mediated quinolone resistance among isolates obtained in a Turkish intensive care unit.
    Nazik H; Ongen B; Kuvat N
    Jpn J Infect Dis; 2008 Jul; 61(4):310-2. PubMed ID: 18653977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Origin of plasmid-mediated quinolone resistance determinant QnrA.
    Poirel L; Rodriguez-Martinez JM; Mammeri H; Liard A; Nordmann P
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3523-5. PubMed ID: 16048974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wide dissemination of a carbapenemase plasmid among gram-negative bacteria: implications of the variable phenotype.
    Espedido B; Iredell J; Thomas L; Zelynski A
    J Clin Microbiol; 2005 Sep; 43(9):4918-9. PubMed ID: 16145178
    [No Abstract]   [Full Text] [Related]  

  • 6. Non-fermentative Gram-negative bacteria.
    Enoch DA; Birkett CI; Ludlam HA
    Int J Antimicrob Agents; 2007 May; 29 Suppl 3():S33-41. PubMed ID: 17659210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluoroquinolone use in children.
    Sabharwal V; Marchant CD
    Pediatr Infect Dis J; 2006 Mar; 25(3):257-8. PubMed ID: 16511391
    [No Abstract]   [Full Text] [Related]  

  • 8. Importance of antibiotic resistance and resistance mechanisms. Foreword.
    Bonomo RA; Rossolini GM
    Expert Rev Anti Infect Ther; 2008 Oct; 6(5):549-50. PubMed ID: 18847392
    [No Abstract]   [Full Text] [Related]  

  • 9. Distribution of the antiseptic-resistance gene qacEDelta1 in 283 clinical isolates of Gram-negative bacteria in China.
    Wang C; Zhan Q; Mi Z; Huang Z; Chen G
    J Hosp Infect; 2008 Aug; 69(4):394-6. PubMed ID: 18511148
    [No Abstract]   [Full Text] [Related]  

  • 10. Multidrug resistant gram-negative bacteria in clinical isolates from Karachi.
    Saeed A; Khatoon H; Ansari FA
    Pak J Pharm Sci; 2009 Jan; 22(1):44-8. PubMed ID: 19168419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial activity of enoxacin.
    Nicoletti G; Caccamo F; Speciale A
    J Chemother; 1989 Jul; 1(4 Suppl):143-4. PubMed ID: 16312344
    [No Abstract]   [Full Text] [Related]  

  • 12. Molecular insights into aminoglycoside action and resistance.
    Magnet S; Blanchard JS
    Chem Rev; 2005 Feb; 105(2):477-98. PubMed ID: 15700953
    [No Abstract]   [Full Text] [Related]  

  • 13. Emerging plasmid-encoded colistin resistance: the animal world as the culprit?
    Poirel L; Nordmann P
    J Antimicrob Chemother; 2016 Aug; 71(8):2326-7. PubMed ID: 27029849
    [No Abstract]   [Full Text] [Related]  

  • 14. Antimicrobial resistance in Europe and its potential impact on empirical therapy.
    Rossolini GM; Mantengoli E
    Clin Microbiol Infect; 2008 Dec; 14 Suppl 6():2-8. PubMed ID: 19040461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimising outcomes of hospital infections through appropriate empirical antimicrobial therapy. Introduction.
    Lode H
    Clin Microbiol Infect; 2008 Apr; 14 Suppl 3():1-2. PubMed ID: 18318873
    [No Abstract]   [Full Text] [Related]  

  • 16. Frequency and antimicrobial susceptibility of Gram-negative bacteria isolated from 2 hospitals in Makkah, Saudi Arabia.
    Al-Mendalawi MD; Asghar AH
    Saudi Med J; 2010 Mar; 31(3):338; author reply 338. PubMed ID: 20231948
    [No Abstract]   [Full Text] [Related]  

  • 17. [Broad-spectrum beta-lactamases in Gram-negative bacteria].
    Sundsfjord A; Simonsen GS; Haldorsen B; Lundblad EW; Samuelsen O
    Tidsskr Nor Laegeforen; 2008 Dec; 128(23):2741-5. PubMed ID: 19079424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Virulence blocking antibiotics. Anti-bacterial agents with completely new action mechanisms].
    Sundin C; Elofsson M; Wolf-Watz H; Rosell S
    Lakartidningen; 2009 Sep 30-Oct 6; 106(40):2543-5. PubMed ID: 19908625
    [No Abstract]   [Full Text] [Related]  

  • 19. What is in the pipeline for Gram-negative pathogens?
    Talbot GH
    Expert Rev Anti Infect Ther; 2008 Feb; 6(1):39-49. PubMed ID: 18251663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial resistance among and therapeutic options against gram-negative pathogens.
    Rahal JJ
    Clin Infect Dis; 2009 Aug; 49 Suppl 1():S4-S10. PubMed ID: 19619021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.